Back to search

University of York

Targeting of the PI3K/AKT/mTOR pathway in human prostate cancer

Abstract

dc:description.abstract

The tumour suppressor PTEN is frequently lost in advanced prostate cancer leading to over-activation of the PI3K/AKT/mTOR pathway. Therefore targeting of the PI3K signalling with pathway-specific inhibitors has been proposed as a therapeutic strategy. Inhibition of AKT and mTOR kinases in prostate cancer cell lines showed a decrease in cell viability and reduction in phospho-biomarkers expression. Although apoptosis was not induced, a decrease in cell migration and G1 cell growth arrest were observed in LNCaP cells. However, in primary prostate cultures activation of the Ras/MEK/ERK compensatory pathway was observed following treatment with AKTi. Moreover, cell viability was less affected than in cell lines and autophagy was induced following treatment with AKTi. Surprisingly, treatment with a combination of AKTi and MEK1/2 inhibitors (MEK1/2i and RO-512) did not reduce phosphorylation of ERK1/2 in primary prostate cultures, but irreversible growth arrest-senescence, was evident. Additionally, ex vivo treatment of a ‘near-patient’ prostate xenograft with a combination of AKTi and mTORi significantly reduced tumour frequency. These results demonstrate that targeting the PI3K/AKT/mTOR pathway triggers activation of the Ras/MEK/ERK compensatory pathway and therefore blockade of one pathway is not sufficient to treat prostate cancer. This study also highlights the importance of using patient-derived tumour cells in preclinical assessment of new drugs rather than relying solely on cancer cell lines.

Degree

thesis:*
Name dc:type.qualificationname
Ph.D
Level dc:type.qualificationlevel
doctoral
Grantor dc:publisher.institution
University of York
Year dc:date.issued
2014

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Butler, Dominika Ewelina
Advisors dc:contributor.advisor
  • Maitland, Norman J
  • Davies, Barry R

Rights

Language dc:language.dcterms_iso639_2
eng

Identifiers

dc:identifier.*
Identifier
uk.bl.ethos.643655

Chain of custody

source
Harvested from
White Rose University Consortium
Base URL
etheses.whiterose.ac.uk/cgi/oai2
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
related terms
citation

Butler, Dominika Ewelina. Targeting of the PI3K/AKT/mTOR pathway in human prostate cancer. doctoral thesis, University of York, 2014.